Operating Expenses 更改
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
Amgen USD 6.93B 2.11B 2023-12
Baxter International USD 3.59B 173M 2023-12
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Biogen USD 2.03B 344.1M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Cara Therapeutics USD 33.76M 5.51M 2023-09
Cipla INR 52.34B 1.6B 2023-09
Dr.Reddys Laboratories INR 52.25B 1.76B 2023-09
Eisai JPY 171.22B 309M 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Exelixis USD 489.5M 97.5M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Grifols EUR 1.35B 73.17M 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Incyte USD 826.07M 121.75M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Ironwood Pharmaceuticals USD 79.96M 6.25M 2023-12
Merck USD 16.56B 6.35B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Takeda JPY 1.09T 202.38B 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
Xencor USD 79.7M 2.27M 2023-12



Nektar Therapeutics 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.